URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Peter Kouides

Concepts (298)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Menorrhagia
21
2001
28
6.890
Why?
von Willebrand Diseases
15
1998
23
5.410
Why?
Hemostasis
8
1998
61
3.280
Why?
Hemophilia A
7
2009
29
2.750
Why?
Hemorrhage
9
2001
173
2.700
Why?
Blood Coagulation Disorders
8
2002
36
1.860
Why?
Menstruation
6
1998
16
1.460
Why?
Coagulants
2
2008
13
1.430
Why?
Antifibrinolytic Agents
5
2008
18
1.340
Why?
Hemostatics
6
2006
23
1.300
Why?
Humans
72
1988
35000
1.200
Why?
Delivery of Health Care
2
2009
136
1.180
Why?
Physician's Practice Patterns
2
2009
223
1.120
Why?
Heparin
2
2005
116
1.090
Why?
Tranexamic Acid
4
2008
7
1.070
Why?
Anticoagulants
2
2005
128
1.060
Why?
Factor VIII
4
2009
50
1.050
Why?
Deamino Arginine Vasopressin
5
2006
23
1.040
Why?
Factor X Deficiency
2
2001
2
1.020
Why?
Female
43
1993
19061
0.960
Why?
Blood Coagulation Factors
5
2001
50
0.960
Why?
Uterine Hemorrhage
2
2004
26
0.940
Why?
Hemophilia B
2
2009
11
0.880
Why?
Biopsy
2
2006
359
0.860
Why?
Myelodysplastic Syndromes
5
1992
129
0.850
Why?
Blood Loss, Surgical
2
2008
44
0.830
Why?
Antibodies, Monoclonal
2
2006
725
0.810
Why?
Blood Platelet Disorders
3
2004
6
0.760
Why?
Thrombosis
1
2012
196
0.700
Why?
Factor IX
1
2009
10
0.690
Why?
Polyps
1
2009
9
0.690
Why?
Perioperative Care
1
2009
21
0.680
Why?
Postoperative Hemorrhage
1
2009
19
0.670
Why?
Venous Thromboembolism
1
2009
21
0.670
Why?
Colonoscopy
1
2009
40
0.660
Why?
Purpura, Thrombocytopenic
3
1995
14
0.660
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2008
89
0.660
Why?
Gastrointestinal Hemorrhage
1
2009
84
0.650
Why?
Factor X
1
2008
16
0.640
Why?
Adult
27
1988
10906
0.620
Why?
Platelet Function Tests
5
2004
14
0.620
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1993
409
0.620
Why?
Pregnancy Complications, Hematologic
4
2001
28
0.610
Why?
von Willebrand Factor
5
2008
59
0.610
Why?
Registries
1
2008
203
0.590
Why?
Lymphoma, T-Cell
1
2007
10
0.580
Why?
Splenic Neoplasms
1
2007
10
0.580
Why?
Crohn Disease
1
2007
88
0.560
Why?
Prostatic Neoplasms
1
2012
548
0.540
Why?
Women
1
2006
16
0.540
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2006
4
0.530
Why?
Liver Neoplasms
1
2007
149
0.530
Why?
Prevalence
4
2005
530
0.530
Why?
Leukemia, Myeloid, Acute
2
1999
172
0.500
Why?
Hysterectomy
1
2004
32
0.480
Why?
Embolization, Therapeutic
1
2004
39
0.470
Why?
Endometrium
1
2004
47
0.460
Why?
Thrombocytopenia
1
2005
71
0.460
Why?
Middle Aged
20
1993
9461
0.450
Why?
Quality of Life
6
2000
486
0.450
Why?
Catheter Ablation
1
2004
72
0.440
Why?
Male
23
1988
18870
0.420
Why?
Child
9
1995
3897
0.420
Why?
Treatment Outcome
7
1993
2487
0.380
Why?
Pregnancy
7
1998
1919
0.380
Why?
Adolescent
10
1993
4513
0.370
Why?
Genitalia, Female
1
2000
23
0.370
Why?
Administration, Oral
3
2009
302
0.360
Why?
Genital Diseases, Female
1
2000
33
0.360
Why?
6-Aminocaproic Acid
2
2009
8
0.360
Why?
Bone Marrow Transplantation
6
1993
189
0.360
Why?
Antineoplastic Agents
1
2006
598
0.360
Why?
Rare Diseases
2
2008
27
0.350
Why?
Young Adult
5
2008
1013
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
1995
42
0.330
Why?
Forecasting
2
2009
172
0.320
Why?
Mass Screening
3
2006
223
0.310
Why?
Cytarabine
2
1995
82
0.310
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
1993
56
0.300
Why?
Blood Coagulation Tests
2
2004
35
0.280
Why?
Sulfhemoglobinemia
1
1996
1
0.270
Why?
Cyanosis
1
1996
5
0.270
Why?
Methylene Blue
1
1996
11
0.270
Why?
Flutamide
1
1996
25
0.270
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.260
Why?
Antineoplastic Agents, Hormonal
1
1996
44
0.260
Why?
Questionnaires
4
2000
942
0.260
Why?
Blast Crisis
1
1995
20
0.260
Why?
Cell Transformation, Neoplastic
2
1995
134
0.250
Why?
Clinical Laboratory Techniques
2
2002
39
0.250
Why?
Red-Cell Aplasia, Pure
1
1995
9
0.250
Why?
Aged
11
1993
6986
0.250
Why?
Leukemia, Lymphoid
1
1995
63
0.250
Why?
Leukemia, Myelomonocytic, Chronic
1
1995
18
0.250
Why?
Pericarditis
1
1995
10
0.250
Why?
Chromosomes, Human, Pair 14
1
1994
16
0.240
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.240
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.240
Why?
Chromosomes, Human, Pair 1
1
1994
24
0.240
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1995
82
0.240
Why?
Burkitt Lymphoma
1
1994
47
0.240
Why?
Translocation, Genetic
1
1994
62
0.230
Why?
Leukemia
1
1995
152
0.230
Why?
Respiratory Distress Syndrome, Adult
1
1995
75
0.230
Why?
Postpartum Hemorrhage
3
2006
8
0.230
Why?
Contraceptives, Oral, Combined
2
2008
5
0.220
Why?
Immunosuppressive Agents
1
1995
200
0.220
Why?
Practice Guidelines as Topic
3
2009
288
0.220
Why?
Sex Characteristics
2
2001
138
0.210
Why?
Retrospective Studies
4
1995
2167
0.210
Why?
Blood Coagulation Factor Inhibitors
1
2012
1
0.200
Why?
Chicago
1
2012
6
0.200
Why?
Hematology
2
2002
13
0.200
Why?
Factor Xa
1
2012
21
0.200
Why?
Charcoal
1
2012
17
0.200
Why?
Antidotes
1
2012
17
0.200
Why?
Congresses as Topic
1
2012
30
0.200
Why?
Blood Coagulation Disorders, Inherited
1
2011
1
0.190
Why?
Prostate-Specific Antigen
1
2012
112
0.190
Why?
Thrombin
1
2012
132
0.190
Why?
Hemorrhagic Disorders
1
2011
5
0.190
Why?
Epistaxis
1
2010
4
0.190
Why?
Hormone Replacement Therapy
1
2011
14
0.190
Why?
Contusions
1
2010
20
0.180
Why?
Immune Tolerance
1
2011
145
0.180
Why?
Medical History Taking
1
2010
59
0.180
Why?
Remission Induction
2
1995
155
0.180
Why?
Vitamin K
1
2009
8
0.170
Why?
Upper Gastrointestinal Tract
1
2009
1
0.170
Why?
Helicobacter Infections
1
2009
6
0.170
Why?
Premedication
1
2009
18
0.170
Why?
Labor, Obstetric
2
1998
31
0.170
Why?
Platelet Transfusion
1
2010
84
0.170
Why?
Biomedical Research
1
2011
132
0.170
Why?
Cyclooxygenase 2 Inhibitors
1
2009
61
0.170
Why?
Prospective Studies
3
1993
1606
0.160
Why?
Administration, Intranasal
1
2009
62
0.160
Why?
Headache
1
2009
46
0.160
Why?
Iran
1
2008
3
0.160
Why?
Deferoxamine
1
1988
15
0.160
Why?
Italy
1
2008
22
0.160
Why?
Cross-Over Studies
1
2009
117
0.160
Why?
Plasma
1
2008
33
0.160
Why?
Disease Management
3
2002
26
0.160
Why?
Homozygote
1
2008
91
0.160
Why?
Risk Factors
2
1998
2172
0.160
Why?
Great Britain
1
2008
95
0.160
Why?
Heterozygote
1
2008
120
0.150
Why?
Follow-Up Studies
3
1995
1757
0.150
Why?
Mutation, Missense
1
2008
81
0.150
Why?
Diagnosis, Differential
3
1997
855
0.150
Why?
Evidence-Based Medicine
1
2009
197
0.150
Why?
Placenta Diseases
1
2007
17
0.150
Why?
Hematologic Tests
1
2007
8
0.150
Why?
Mastocytosis, Systemic
1
2007
4
0.150
Why?
Pneumonia, Pneumocystis
1
1988
118
0.140
Why?
Arteries
1
2007
77
0.140
Why?
Genotype
1
2008
455
0.140
Why?
Infant
2
2008
2102
0.140
Why?
Recombinant Proteins
1
2009
706
0.140
Why?
Randomized Controlled Trials as Topic
2
2004
400
0.140
Why?
Placenta
1
2007
143
0.140
Why?
Menstruation Disturbances
1
2006
9
0.140
Why?
Pain
1
2009
363
0.130
Why?
Lymphoma
2
1993
151
0.130
Why?
Severity of Illness Index
2
1993
878
0.130
Why?
Injections, Intravenous
1
2006
125
0.130
Why?
Antibodies, Monoclonal, Murine-Derived
1
2006
124
0.120
Why?
Lymphoma, Follicular
1
2006
54
0.120
Why?
Lymphoma, Non-Hodgkin
2
1995
105
0.120
Why?
Dexamethasone
1
2006
176
0.120
Why?
Anti-Inflammatory Agents
1
2006
109
0.120
Why?
Postoperative Period
1
2004
78
0.120
Why?
Heavy Chain Disease
1
2003
2
0.110
Why?
Immunoglobulin lambda-Chains
1
2003
20
0.110
Why?
Amyloidosis
1
2003
29
0.110
Why?
Infant, Newborn
1
2008
1772
0.110
Why?
Thalassemia
2
1988
21
0.110
Why?
Immunoglobulin Heavy Chains
1
2003
45
0.110
Why?
Skin
1
2006
370
0.110
Why?
Child, Preschool
4
1997
2452
0.110
Why?
Hodgkin Disease
2
1993
152
0.100
Why?
Premenopause
1
2002
12
0.100
Why?
Postmenopause
1
2002
42
0.100
Why?
Physical Examination
1
2002
88
0.100
Why?
Obstetric Labor Complications
1
2001
19
0.100
Why?
Home Infusion Therapy
1
2001
1
0.090
Why?
Transplantation, Homologous
2
1995
261
0.090
Why?
Prognosis
3
1993
1030
0.090
Why?
Meninges
1
1999
18
0.090
Why?
Fatal Outcome
2
1996
101
0.080
Why?
United States
3
2011
2511
0.080
Why?
Flow Cytometry
2
1995
597
0.080
Why?
Multiple Myeloma
1
1999
73
0.080
Why?
Platelet Aggregation
2
2007
63
0.080
Why?
Meningeal Neoplasms
1
1999
46
0.080
Why?
Corynebacterium Infections
1
1998
8
0.080
Why?
Parvoviridae Infections
1
1998
12
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
Risk Assessment
3
2002
808
0.080
Why?
Algorithms
1
2002
518
0.080
Why?
Cohort Studies
2
2011
912
0.070
Why?
Anemia, Sideroblastic
1
1997
8
0.070
Why?
Copper
1
1997
51
0.070
Why?
Brain Neoplasms
1
1999
254
0.070
Why?
Methemoglobinemia
1
1996
1
0.070
Why?
Anemia
1
1997
76
0.070
Why?
Aged, 80 and over
2
1995
2423
0.070
Why?
Sex Factors
1
1998
561
0.070
Why?
Treatment Failure
1
1996
125
0.070
Why?
Case-Control Studies
2
2004
587
0.070
Why?
Recurrence
4
1993
656
0.060
Why?
Hypersensitivity, Delayed
1
1996
52
0.060
Why?
Daunorubicin
1
1995
25
0.060
Why?
Clinical Trials as Topic
2
2008
664
0.060
Why?
Antineoplastic Agents, Alkylating
1
1996
38
0.060
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
1995
12
0.060
Why?
Drug Hypersensitivity
1
1996
44
0.060
Why?
Cyclophosphamide
1
1996
169
0.060
Why?
Immunophenotyping
1
1995
123
0.060
Why?
Hepatitis B
1
1995
21
0.060
Why?
Neoplasm Metastasis
1
1996
219
0.060
Why?
Hydroxyquinolines
1
1993
9
0.060
Why?
Acute Disease
2
1995
570
0.050
Why?
Bone Marrow
1
1994
282
0.050
Why?
Apoptosis
1
1999
782
0.050
Why?
Adjuvants, Immunologic
1
1993
118
0.050
Why?
Stem Cell Transplantation
1
1993
108
0.050
Why?
Drug Monitoring
1
2012
39
0.050
Why?
Drug Interactions
1
2012
176
0.050
Why?
Contraceptive Agents, Female
1
2011
3
0.050
Why?
Drug Combinations
1
2011
142
0.050
Why?
Hematologic Diseases
1
2011
40
0.050
Why?
Hematopoiesis
1
1992
128
0.050
Why?
Menstrual Cycle
1
2011
12
0.050
Why?
Transplantation, Autologous
3
1993
136
0.050
Why?
Protein C
1
2011
31
0.050
Why?
Population Surveillance
1
2011
120
0.050
Why?
Electrocardiography
1
1995
719
0.040
Why?
Longitudinal Studies
1
2011
372
0.040
Why?
Decision Trees
1
2009
27
0.040
Why?
Joint Diseases
1
2009
30
0.040
Why?
Liver Diseases
1
2009
78
0.040
Why?
Phenotype
1
2011
727
0.040
Why?
Kidney Failure, Chronic
1
2009
117
0.040
Why?
Intrauterine Devices, Medicated
1
2008
1
0.040
Why?
Levonorgestrel
1
2008
3
0.040
Why?
Danazol
1
2008
4
0.040
Why?
Progestins
1
2008
16
0.040
Why?
Hypertension, Malignant
1
2007
5
0.040
Why?
Purpura, Thrombotic Thrombocytopenic
1
2007
10
0.040
Why?
Hemostasis, Surgical
1
2008
12
0.040
Why?
Plasmapheresis
1
2007
25
0.040
Why?
ADAM Proteins
1
2007
11
0.040
Why?
Ticlopidine
1
2007
5
0.040
Why?
Plasma Exchange
1
2007
16
0.040
Why?
Gonadotropin-Releasing Hormone
1
2008
43
0.040
Why?
Pre-Eclampsia
1
2007
24
0.040
Why?
Comorbidity
1
2009
365
0.040
Why?
Platelet Aggregation Inhibitors
1
2007
57
0.040
Why?
Aspirin
1
2007
58
0.040
Why?
Drug Resistance
1
2007
97
0.040
Why?
Prednisone
1
2007
178
0.030
Why?
Drug Therapy, Combination
1
2007
375
0.030
Why?
Cardiovascular Diseases
1
2009
250
0.030
Why?
Coagulation Protein Disorders
1
2004
1
0.030
Why?
Fluorescent Antibody Technique, Direct
1
2003
8
0.030
Why?
Basement Membrane
1
2003
33
0.030
Why?
Kidney Glomerulus
1
2003
28
0.030
Why?
Nephrotic Syndrome
1
2003
28
0.030
Why?
Amyloid
1
2003
19
0.030
Why?
Reference Values
1
2004
427
0.030
Why?
Neoplasms
1
2009
701
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2003
124
0.030
Why?
Combined Modality Therapy
2
1993
459
0.020
Why?
Sensitivity and Specificity
1
2004
866
0.020
Why?
Granulocytes
1
1999
80
0.020
Why?
Bone Marrow Examination
1
1998
25
0.020
Why?
Blood Cell Count
1
1998
44
0.020
Why?
Radiotherapy
1
1999
179
0.020
Why?
Cerebral Cortex
1
1999
235
0.020
Why?
Bone Marrow Cells
1
1998
220
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Skin Tests
1
1996
35
0.020
Why?
Immunoglobulin E
1
1996
58
0.020
Why?
Multivariate Analysis
1
1997
487
0.020
Why?
Hepatitis B Surface Antigens
1
1995
5
0.020
Why?
Hepatitis B e Antigens
1
1995
3
0.020
Why?
Antibodies
1
1996
207
0.010
Why?
Disease-Free Survival
1
1995
191
0.010
Why?
Actuarial Analysis
1
1993
20
0.010
Why?
Leukemia, Myeloid
1
1995
115
0.010
Why?
Survival Rate
1
1995
584
0.010
Why?
Proportional Hazards Models
1
1993
398
0.010
Why?
Age Factors
1
1995
1060
0.010
Why?
Predictive Value of Tests
1
1993
579
0.010
Why?
Survival Analysis
1
1993
575
0.010
Why?
Time Factors
1
1996
3047
0.010
Why?

Visualizations


Kouides's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department